Form 4: Director Gehl Acquires Marcus Corp Restricted Stock
Insider Transaction Report
Marcus Corp Director Katherine M. Gehl reported the acquisition of 4,174 restricted shares of common stock and detailed her beneficial ownership of common stock and stock options.
Summary
- Katherine M. Gehl, a Director of The Marcus Corporation (MCS), reported an acquisition of 4,174 shares of common stock on December 31, 2025.
- These shares were granted as restricted stock at a price of $0.
- The restricted stock vests 50% after the second anniversary and 100% after the fourth anniversary of the grant date.
- Following this transaction, Katherine M. Gehl beneficially owns 17,081 shares indirectly through the Katherine M. Gehl 2005 Trust.
- Additionally, she directly owns 22,034 shares of common stock.
- She also holds 7,643 stock options directly, with various exercise prices ranging from $14.25 to $38.51 and expiration dates between December 2026 and December 2033. These options were granted under The Marcus Corporation 2004 Equity and Incentive Awards Plan.
Sentiment
Score: 7
Explanation: The acquisition of restricted stock by a director, while a positive sign of alignment, is a standard compensation event rather than a discretionary open-market purchase, thus indicating a moderately positive sentiment.
Positives
- Director Katherine M. Gehl acquired 4,174 shares of common stock, indicating continued alignment of her interests with shareholders.
- The acquisition was a grant of restricted stock at a $0 price, representing a direct increase in her equity holdings without personal cash outlay.
- The vesting schedule for the restricted stock (50% after 2 years, 100% after 4 years) suggests a long-term commitment to the company.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's future performance. It primarily reports an insider transaction and beneficial ownership.
Industry Context
This Form 4 filing, reporting an insider's acquisition of restricted stock, is a routine disclosure in the context of corporate compensation and governance. It does not provide broader industry trends or competitive analysis.
Comparison to Industry Standards
- The grant of restricted stock to a director is a common practice in corporate compensation across various industries, aligning director incentives with long-term shareholder value.
- The specific vesting schedule (50% after 2 years, 100% after 4 years) is within typical industry ranges for such grants, designed to encourage sustained commitment.
- No specific comparable companies or projects are mentioned in the filing.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Plan Usage | The stock options were granted pursuant to The Marcus Corporation 2004 Equity and Incentive Awards Plan, indicating the use of an established corporate governance framework for equity compensation. | N/A | Reinforces existing compensation structure and aligns director incentives with long-term company performance. |
Related Party Transactions
- Katherine M. Gehl's indirect beneficial ownership of 17,081 shares through the Katherine M. Gehl 2005 Trust constitutes a related party holding.
Stakeholder Impact
- Shareholders: The acquisition of restricted stock by a director aligns management's interests with shareholders, potentially fostering long-term value creation.
- Employees: No direct impact on employees is indicated, though equity plans can be a broader incentive.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.
Next Steps
- The 4,174 restricted shares will vest 50% after December 31, 2027, and 100% after December 31, 2029.
Key Dates
| Date | Description |
|---|---|
| 12/29/2016 | Date exercisable for 1,000 stock options with an exercise price of $31.55. |
| 12/28/2017 | Date exercisable for 1,000 stock options with an exercise price of $27.20. |
| 12/27/2018 | Date exercisable for 1,000 stock options with an exercise price of $38.51. |
| 12/26/2019 | Date exercisable for 1,000 stock options with an exercise price of $32.60. |
| 12/30/2021 | Date exercisable for 750 stock options with an exercise price of $17.95. |
| 12/29/2022 | Date exercisable for 1,438 stock options with an exercise price of $14.25. |
| 12/28/2023 | Date exercisable for 1,455 stock options with an exercise price of $14.69. |
| 12/31/2025 | Date of grant for 4,174 restricted shares of common stock. |
| 01/05/2026 | Filing date of the Form 4. |
| 12/29/2026 | Expiration date for 1,000 stock options with an exercise price of $31.55. |
| 12/28/2027 | Expiration date for 1,000 stock options with an exercise price of $27.20. |
| 12/31/2027 | Expected vesting of 50% of the 4,174 restricted shares (2 years after grant). |
| 12/27/2028 | Expiration date for 1,000 stock options with an exercise price of $38.51. |
| 12/26/2029 | Expiration date for 1,000 stock options with an exercise price of $32.60. |
| 12/31/2029 | Expected vesting of 100% of the 4,174 restricted shares (4 years after grant). |
| 12/30/2031 | Expiration date for 750 stock options with an exercise price of $17.95. |
| 12/29/2032 | Expiration date for 1,438 stock options with an exercise price of $14.25. |
| 12/28/2033 | Expiration date for 1,455 stock options with an exercise price of $14.69. |
Recommendation
holdWhile the director's acquisition of restricted stock is a positive signal of alignment and commitment, it is a routine compensation event rather than a discretionary open-market purchase. This filing alone does not provide sufficient new information to warrant a 'buy' or 'sell' recommendation, suggesting a 'hold' position for investors awaiting broader company performance updates or more significant insider trading activity.
Keywords
Marcus Corp, MCS, Katherine M. Gehl, Director, SEC Form 4, Insider Trading, Restricted Stock, Stock Options, Beneficial Ownership, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.